Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

74 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
"Incidence and significance of donor-specific antibodies in haploidentical stem cell transplantation".
Altareb M, Al-Awwami M, Alfraih F, Alhayli S, Ahmed SO, Shaheen M, Chaudhri N, Alsharif F, Alkhabbaz H, Albabtain AA, Alfayez M, Hanbali A, Alshaibani A, Alotaibi AS, Rasheed W, Algharably A, Almohareb F, Alahmari A, Alzahrani H, Aljurf M, El Fakih R. Altareb M, et al. Among authors: alotaibi as. Bone Marrow Transplant. 2023 Jun;58(6):680-686. doi: 10.1038/s41409-023-01950-4. Epub 2023 Mar 23. Bone Marrow Transplant. 2023. PMID: 36959370
Improved survival of adolescents and young adults patients with T-cell acute lymphoblastic leukemia.
Hanbali A, Kotb A, Fakih RE, Alfraih F, Shihata N, Rasheed W, Ahmed SO, Shaheen M, Alhayli S, Alahmari A, Alotaibi A, Alshaibani A, Albabtain A, Alfayez M, Hassan M, Alsharif F, Chaudhri N, Almohareb F, Alzahrani H, Aljurf M. Hanbali A, et al. Int J Hematol Oncol. 2023 Feb 27;12(1):IJH42. doi: 10.2217/ijh-2022-0005. eCollection 2023 Feb. Int J Hematol Oncol. 2023. PMID: 36874377 Free PMC article.
Incidence and risk factors for secondary graft failure in uniformly treated patients with severe aplastic anemia receiving fludarabine and cyclophosphamide for conditioning and matched sibling bone marrow graft as stem cell source.
Kotb A, Alzahrani H, Alahmari A, Syed Osman Ahmed, Alhayli S, Shaheen M, Chaudhri N, Alsharif F, Hanbali A, Alfraih F, Alshaibani A, Albabtain AA, Alfayez M, Alotaibi AS, Elhassan T, Rasheed W, Almohareb F, Aljurf M, El Fakih R. Kotb A, et al. Among authors: alotaibi as. Cytotherapy. 2023 Dec;25(12):1331-1337. doi: 10.1016/j.jcyt.2023.08.009. Epub 2023 Sep 19. Cytotherapy. 2023. PMID: 37737766
Myeloablative Haploidentical Donor Hematopoietic Transplantation Using Post-Transplantation Cyclophosphamide and Antithymocyte Globulin.
El Fakih R, Nassani M, Rasheed W, Hanbali A, Almohareb F, Chaudhri N, Alsharif F, Alfraih F, Shaheen M, Alhayli S, Alkhaldi H, Alshaibani A, Alotaibi AS, Alahmari A, Alamer A, Tarig A, Youniss R, Albabtain AA, Alfayez M, Saad A, Ahmed SO, Alzahrani H, Aljurf M. El Fakih R, et al. Among authors: alotaibi as. Transplant Cell Ther. 2024 Mar;30(3):312.e1-312.e7. doi: 10.1016/j.jtct.2024.01.054. Epub 2024 Jan 5. Transplant Cell Ther. 2024. PMID: 38185379
Efficacy and Safety of Mepolizumab in the Management of Severe Eosinophilic Asthma: A Systematic Review.
Dighriri IM, Alnughaythir AI, Albesisi AA, Alhuwaimel DI, Alotaibi AS, Alghowaidi LA, Almalki FH, Al-Bukhari JN, Alshammari TR, Alwathnani FH, Alghamdi AA, Alghamdi AA, Alshehri SD, Mahnashi NY, Abu Jamilah HA. Dighriri IM, et al. Among authors: alotaibi as. Cureus. 2023 Dec 1;15(12):e49781. doi: 10.7759/cureus.49781. eCollection 2023 Dec. Cureus. 2023. PMID: 38161547 Free PMC article. Review.
74 results